Patent Assignment
Reel/Frame 053174/0561
Assignment of Assignor's Interest
Recorded: 2020-07-10
Pages: 4
Assignor
ASTEX PHARAMCEUTICALS, INC.
Executed: 2013-06-05
Assignee
TOLERO PHARMACEUTICALS, INC.
3900 N. TRAVERSE MOUNTAIN BLVD., LEHI, UTAH, 84043
Covered Property
(1)
Heterocyclic Protein Kinase Inhibitors
PCT:
PCT/US2012/047685 ↗
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 10, 2020
From: XU, YONG; BRENNING, BENJAMIN GARY; KULTGEN, STEVEN G.; LIU, XIAOHUI
To: ASTEX PHARMACEUTICALS, INC.
Reel/Frame 053174/0449 →
Merger
Jul 16, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053225/0444 →
Change of Name
Jul 16, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053225/0690 →
Corrective Assignment to Correct the Receiving Party Name Previously Recorded on Reel 053225 Frame 0444. Assignor(S) Hereby Confirms the Merger.
Jul 17, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053242/0090 →
Change of Name
Apr 25, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059787/0758 →